Recurrent hyperactive ESR1 fusion proteins in endocrine therapy resistant breast cancer.
| Author | :
|
|---|---|
| Abstract | :
ER-positive metastatic breast cancer is often intractable due to endocrine therapy resistance. Although ESR1 promoter switching events have been associated endocrine-therapy resistance, recurrent ESR1 fusion proteins have yet to be identified in advanced breast cancer. |
| Year of Publication | :
2018
|
| Journal | :
Annals of oncology : official journal of the European Society for Medical Oncology
|
| Date Published | :
2018
|
| ISSN Number | :
0923-7534
|
| URL | :
https://academic.oup.com/annonc/article-lookup/doi/10.1093/annonc/mdy025
|
| DOI | :
10.1093/annonc/mdy025
|
| Short Title | :
Ann Oncol
|
| Download citation |